Market Tracker

08/22 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

4.14
Data as of Aug 22
 +0.08 / +1.97%
Today’s Change
2.97
Today|||52-Week Range
9.14
-27.87%
Year-to-Date

Today’s Trading

Previous close4.06
Today’s open3.93
Day’s range3.93 - 4.20
Volume128,004
Average volume (3 months)87,852
Market cap$78.3M
Dividend yield--
Data as of 3:59pm ET, 08/22/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-5.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.07-0.79%
APPYVenaxis Inc+0.03+1.73%
GBIMGlobeImmune Inc+0.08+0.88%
LPDXLipoScience Inc+0.02+0.86%
Data as of 3:59pm ET, 08/22/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts